Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
618.27B
Market cap618.27B
Price-Earnings ratio
29.96
Price-Earnings ratio29.96
Dividend yield
2.02%
Dividend yield2.02%
Average volume
8.71M
Average volume8.71M
High today
$261.30
High today$261.30
Low today
$255.52
Low today$255.52
Open price
$259.94
Open price$259.94
Volume
3.32M
Volume3.32M
52 Week high
$269.43
52 Week high$269.43
52 Week low
$154.80
52 Week low$154.80

Stock Snapshot

With a market cap of 618.27B, Johnson & Johnson(JNJ) trades at $256.84. The stock has a price-to-earnings ratio of 29.96 and currently yields dividends of 2.02%.

As of 2026-07-10, Johnson & Johnson(JNJ) stock has fluctuated between $255.52 and $261.30. The current price stands at $256.84, placing the stock +0.5% above today's low and -1.7% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 3.32M, compared to an average daily volume of 8.71M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

JNJ News

TipRanks 55m
JNJ Backs New Heart Failure Device Trial: What Investors Should Watch

Johnson & Johnson (JNJ) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for...

TipRanks 7h
Johnson & Johnson price target raised to $263 from $254 at BofA

BofA raised the firm’s price target on Johnson & Johnson to $263 from $254 and keeps a Neutral rating on the shares. Second quarter results are expected to high...

Simply Wall St 22h
Johnson & Johnson Wins FDA Nod For Dual Energy Heart Rhythm Catheter

Johnson & Johnson (NYSE:JNJ) has received FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, a catheter ablation system that supports both radi...

Johnson & Johnson Wins FDA Nod For Dual Energy Heart Rhythm Catheter

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

New York Times 24h
How Twins scout Sean Johnson prepares for highest draft pick in a decade - The New York Times

...

How Twins scout Sean Johnson prepares for highest draft pick in a decade - The New York Times
24/7 Wall St. 1d
How a $1 Million Dividend Portfolio Can Generate $100,000 Annually

How a $1 Million Dividend Portfolio Can Generate $100,000 Annually By Joel South Published Jul 9, 8:30AM EDT Quick Read Ares Capital's 11% yield nearly genera...

How a $1 Million Dividend Portfolio Can Generate $100,000 Annually
24/7 Wall St. 2d
How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing

How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing By Drew Wood Published Jul 8, 7:11AM EDT Quick Read Replacing $80,000 in annual retire...

How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing
Simply Wall St 2d
Johnson & Johnson Highlights IMAAVY Data, Is The Stock Above Fair Value?

Johnson & Johnson (JNJ) is back in focus after releasing detailed IMAAVY data in generalized myasthenia gravis at the European Academy of Neurology Congress, wh...

Johnson & Johnson Highlights IMAAVY Data, Is The Stock Above Fair Value?
24/7 Wall St. 3d
The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later By Drew Wood Published Jul 7, 4:23PM EDT Quick Read A 3.5% yield growing...

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later
24/7 Wall St. 3d
The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared

The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared By Drew Wood Published Jul 7, 6:39AM EDT Quick Read Generating $1,500 mont...

The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared
Investor's Business Daily 4d
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings

IBD Stock Of The Day Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings Licensing Johnson & Johnson Johnson & Johnson JNJ $ 256.74 $6.30...

Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.